DARMSTADT, Germany — Merck has received approval for a new version of GONAL-f (follitropin alfa injection) prefilled pen from the U.S. Food and Drug Administration (FDA). Known as GONAL-f RFF Redi-ject prefilled pen in the U.S. and originally approved by the FDA in 2013, the new version of the pen is easy-to-learn and easy-to-use. “Aspiring
Amid the shakeout from President Donald Trump’s statements on the violence erupting in protests in Charlottesville, Va., Merck & Co. chairman and CEO Kenneth Frazier said he’s leaving the President’s American Manufacturing Council. Frazier said in a statement posted on Twitter early Monday morning, “I am resigning from the President’s American Manufacturing Council. Our country’s
KENILWORTH, N.J. — Sanat Chattopadhyay has been promoted to executive vice president and president of the Merck Manufacturing Division (MMD). Plans call for Chattopadhyay, currently senior vice president of Global Manufacturing Operations (Human Health), to start in the new position on April 1. He succeeds Willie Deese who will retire on June 1 after 12 years
KENILWORTH, N.J. — Merck has received approval from the Food and Drug Administration for an expanded age indication for Gardasil 9, its 9-valent human papillomavirus (HPV) vaccine. The company said the new indication allows Gardasil 9 to include use in males ages 16 to 26 years for the prevention of anal cancer caused by HPV
PRINCETON, N.J. — Former Merck executive Rhonda Johnson has joined consulting company Market Performance Group (MPG) as executive vice president and client lead. Johnson was Merck Customer Care’s U.S. Region chief customer officer. “MPG has gained a great resource and leader in Rhonda,” said Marc Greenberger, the company’s managing partner. “She’s a dynamic, seasoned executive
DEERFIELD, Ill. — Jeff Berkowitz, executive vice president at Walgreens Boots Alliance and president of Pharma and Global Market Access, has left the company. “With the restructuring of our Pharma and Global Market Access group, Jeff Berkowitz, who has led that function since its formation, has made the decision to pursue other opportunities outside the
PRINCETON JUNCTION, N.J. — Market Performance Group (MPG) announced that founding partner Tim Toohey is retiring and that the company has named two new members to its advisory board. MPG said Tuesday that Toohey is retiring to pursue other business and personal interests but will continue to contribute his knowledge and consulting expertise as a
WASHINGTON — A Food and Drug Administration panel has recommended that the agency approve what could become the country’s first biosimilar. The panel unanimously urged approval of Sandoz’s filgrastin (Neupogen), a cancer treatment. “This encouraging step forward means that it is very likely now only a question of when, rather than if, filgrastin will be available
